Global Oncology Blood Testing Market By Test Type (Liquid Biopsy Assays, Tumor Marker Test, NIPT (Non-Invasive Prenatal Testing) Test, Exome-Based Liquid Biopsy, CTC-based Test, CBC Test, and Blood Protein Test), By Application (Lung Cancer, Ovarian Cancer, Melanoma, Gastrointestinal Stromal Tumor (GIST), Colon Cancer, and Breast Cancer), By End-user (Hospitals, Diagnostic Laboratories, and Specialty Clinics), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview Global Oncology Blood Testing Market size is expected to be worth around US$ 21.4 Billion by 2034 from US$ 5.2 Billion in 2024, growing at a CAGR of 15.2% during the ...
